Wednesday, February 10, 2010, 8:07pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Quidel Corp. (QDEL)

At 5:00AM SGT: 12.63 USD   0.00 (0.00%)  
 MORE ON QDEL 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Quidel Corporation (NasdaqNM:QDEL) Delayed quote dataEdit
Last Trade:12.63 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:12.63
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:18.67
Day's Range:N/A - N/A
52wk Range:7.05 - 18.81
Volume:0
Avg Vol (3m):356,536
Market Cap:380.74M
P/E (ttm):20.77
EPS (ttm):0.61
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add QDEL to Portfolio   Download Data

 HEADLINES 
•Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010
Business Wire (Fri, Jan 29)
•3 Healthy Small Caps
at Investopedia (Fri, Jan 29)
•Scott Brown Health Care Buys
at Forbes.com (Tue, Jan 26)
•An In-Depth Look At Diagnostics Companies And Stock Evaluations From Dr. Ashim Anand Of Natixis Bleichroeder, LLC
Wall Street Transcript (Mon, Jan 25)
•QUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 23)
•[$$] Two Picks Among Life-Science Suppliers
at Barrons.com (Thu, Jan 14)
•Ohio University Proves 26 Years Is Worth The Wait
at The Wall Street Journal Online (Wed, Jan 13)
•Quidel buying Diagnostic Hybrids for $130 million
AP (Tue, Jan 12)
•QUIDEL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Mon, Jan 11)
•Quidel Corporation Announces Definitive Agreement to Acquire Diagnostic Hybrids
Business Wire (Mon, Jan 11)
•Quidel Corporation to Present at the 28th Annual J.P. Morgan Healthcare Conference
Business Wire (Mon, Jan 4)
More Headlines for QDEL...
 ANALYST 
EPS Est (next year) (Dec-09) :0.90
EPS Est (in 2 years) (Dec-10) :0.66
Avg Rec (current)*:1.6
PEG Ratio:0.85
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC) diagnostic solutions for infectious diseases, and reproductive and women's health.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices